Overview of the 2022 WHO Classification of Parathyroid Tumors

The 2022 WHO classification reflects increases in the knowledge of the underlying pathogenesis of parathyroid disease. In addition to the classic characteristic features of parathyroid neoplasms, subtleties in histologic features which may indicate an underlying genetic abnormality reflect increased...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Endocrine pathology Jg. 33; H. 1; S. 64 - 89
Hauptverfasser:	Erickson, Lori A., Mete, Ozgur, Juhlin, C. Christofer, Perren, Aurel, Gill, Anthony J.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	New York Springer US 01.03.2022 Springer Nature B.V
Schlagworte:	Adenoma Blood clots Carcinoma Classification Endocrinology Hyperparathyroidism Hyperplasia Immunohistochemistry Medicine Medicine & Public Health Metastases Mitosis Neoplasia Neuroendocrine tumors Nucleoli Oncology Parathyroid Parathyroidectomy Pathogenesis Pathology Patients Renal failure Thrombosis Tumor cells Tumors Parathyroid hyperplasia Inherited hyperparathyroidism Parathyroid adenoma Atypical parathyroid tumor WHO classification Hyperparathyroidism Parathyroid carcinoma Multiglandular parathyroid disease Parafibromin
ISSN:	1046-3976, 1559-0097, 1559-0097
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!